Mr David Allen Yazdan Sr, MD | |
1530 Route 88, Brick, NJ 08724-2320 | |
(732) 458-6556 | |
(732) 458-3267 |
Full Name | Mr David Allen Yazdan Sr |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 1530 Route 88, Brick, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265418768 | NPI | - | NPPES |
2853906 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | MA22775 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr David Allen Yazdan Sr, MD 1530 Highway 88, Brick, NJ 08724-2320 Ph: (732) 458-6556 | Mr David Allen Yazdan Sr, MD 1530 Route 88, Brick, NJ 08724-2320 Ph: (732) 458-6556 |
News Archive
Our findings suggest that women who are more fatigued, stressed and anxious eat more food, particularly carbohydrates. While eating more food led to an increase in some important micronutrients, it also led to a decrease in others, like folate and vitamin C
Scientists at the Hebrew University of Jerusalem have reported a major breakthrough in understanding the molecular basis for Prader-Willi syndrome (PWS), perhaps the most studied among the class of diseases that involves defects in parental imprinting.
With the launch of the Caya contoured diaphragm this June, women in the United States will have access to a method of contraception that is nonhormonal, has few side effects, and can be used for up to two years. Last fall, the United States Food and Drug Administration cleared the single-size Caya contoured diaphragm for marketing in the US, and now the diaphragm is available by prescription from healthcare providers.
Abiomed Inc., a leading provider of breakthrough heart support technologies, today announced its schedule of events at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, scheduled from September 21 - 25, at the Washington Convention Center in Washington, DC.
Using SARS-CoV-2, a team of scientists from the United States has recently developed a bioengineered bacteriophage T4 nanoparticle structure using CRISPR technology that can be used as a universal platform to produce vaccines.
› Verified 1 days ago